Clinical Trial Update: Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

View source ↗

Summary

This document reports the completed status of the Firazyr patient registry, the Icatibant Outcome Survey (IOS), tracking outcomes in hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Firazyr (icatibant)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema (HAE) | Status: COMPLETED